Marie Claude Morice

Summary

Affiliation: Institut Cardiovasculaire Paris Sud
Country: France

Publications

  1. doi request reprint SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Paris, France
    EuroIntervention 8:325-35. 2012
  2. ncbi request reprint Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 50:1299-304. 2007
  3. ncbi request reprint [Results of the French register of renal stenting: the Esternal study]
    M C Morice
    Institut Cardiovasculaire Paris Sud, Massy
    Arch Mal Coeur Vaiss 100:827-32. 2007
  4. doi request reprint XIENCE V SPIRIT WOMEN clinical trial: characterization of the female population undergoing stent implantation
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, ICPS, 6 avenue du Noyer Lambert, 91300 Massy, France
    Womens Health (Lond Engl) 4:439-43. 2008
  5. ncbi request reprint Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    JAMA 295:895-904. 2006
  6. doi request reprint What can we expect from quantitative OCT?
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 72:236. 2008
  7. doi request reprint Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, Massy, France
    Circulation 121:2645-53. 2010
  8. doi request reprint Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:670-9. 2011
  9. ncbi request reprint Stenting for small coronary vessels
    Marie Claude Morice
    L Institut Cardiovasculaire Paris Sud, Antony, France
    J Invasive Cardiol 15:377-9. 2003
  10. doi request reprint Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Yusuke Watanabe
    Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 81:1053-60. 2013

Detail Information

Publications67

  1. doi request reprint SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Paris, France
    EuroIntervention 8:325-35. 2012
    ..SPIRIT Women is the first interventional trial dedicated exclusively to women, focusing on symptoms at presentation, referral time to coronary intervention and the safety and performance of the XIENCE V stent...
  2. ncbi request reprint Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 50:1299-304. 2007
    ..This study examined the clinical outcomes at 5 years in RAVEL (A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization), the first controlled trial of drug-eluting stents...
  3. ncbi request reprint [Results of the French register of renal stenting: the Esternal study]
    M C Morice
    Institut Cardiovasculaire Paris Sud, Massy
    Arch Mal Coeur Vaiss 100:827-32. 2007
    ..7 +/- 17.1 ml/min vs. 69.2 +/- 160.3. Renal artery stenting in cardiac patients with renal artery stenosis is associated with a very high success rate, with few complications and an improvement in hypertension and renal function...
  4. doi request reprint XIENCE V SPIRIT WOMEN clinical trial: characterization of the female population undergoing stent implantation
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, ICPS, 6 avenue du Noyer Lambert, 91300 Massy, France
    Womens Health (Lond Engl) 4:439-43. 2008
    ..In total, approximately 2000 female patients, derived from the general interventional cardiology population, will be enrolled from up to 130 sites outside of the USA...
  5. ncbi request reprint Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    JAMA 295:895-904. 2006
    ....
  6. doi request reprint What can we expect from quantitative OCT?
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 72:236. 2008
  7. doi request reprint Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, Massy, France
    Circulation 121:2645-53. 2010
    ....
  8. doi request reprint Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:670-9. 2011
    ..The SYNTAX-LE MANS substudy prospectively evaluated 15-month angiographic and clinical outcomes in patients with treated left main (LM) disease...
  9. ncbi request reprint Stenting for small coronary vessels
    Marie Claude Morice
    L Institut Cardiovasculaire Paris Sud, Antony, France
    J Invasive Cardiol 15:377-9. 2003
  10. doi request reprint Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
    Yusuke Watanabe
    Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 81:1053-60. 2013
    ..The purpose of this study was to examine the performance of the European system for cardiac operative risk evaluation II (ESII) in patients undergoing transcatheter aortic valve implantation (TAVI)...
  11. doi request reprint Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    Circ Cardiovasc Interv 6:284-91. 2013
    ..The purpose of this study was to evaluate the efficacy and safety of transcatheter aortic valve implantation in patients with BAV...
  12. doi request reprint Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study
    Neus Salvatella
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:689-96. 2011
    ....
  13. doi request reprint Transfemoral aortic valve implantation new criteria to predict vascular complications
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 4:851-8. 2011
    ..This study sought to evaluate the incidence, impact, and predictors of vascular complications in transcatheter aortic valve implantation (TAVI)...
  14. ncbi request reprint A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    N Engl J Med 346:1773-80. 2002
    ..Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris...
  15. doi request reprint Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 59:566-71. 2012
    ..The purpose of this study was to clarify the impact of sex-related differences in transcatheter aortic valve implantation (TAVI) for high-risk patients with severe aortic stenosis...
  16. doi request reprint Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 5:1247-56. 2012
    ..The goal of the study was to clarify the impact of post-procedural aortic regurgitation (post-AR) grade 2/4 on clinical outcomes...
  17. doi request reprint Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    EuroIntervention 8:546-55. 2012
    ..However, computed tomography (CT) has potential advantages compared to TEE. We sought to assess the impact of CT-guided valve sizing on post-procedural aortic regurgitation (AR)...
  18. doi request reprint Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry
    Darren Mylotte
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, 6 Avenue du Noyer Lamber, Massy, France
    EuroIntervention 8:970-81. 2012
    ..Limited long-term data are available to support drug-eluting stent (DES) unprotected left main (LM) intervention. We sought to evaluate long-term outcomes of LM intervention with paclitaxel-eluting stents...
  19. doi request reprint Reproducibility and factors influencing the assessment of the SYNTAX score in the left main Xience study
    Philippe Garot
    Hôpital Claude Galien and Institut Jacques Cartier, Institut Cardiovasculaire Paris Sud, Massy and Quincy, France
    Catheter Cardiovasc Interv 80:231-7. 2012
    ..As assessment of SYNTAX score is made by visual estimate of coronary angiography, discrepancies between evaluations by different observers and the impact of observer experience have not yet been evaluated...
  20. ncbi request reprint Triple vessel stenting for triple vessel coronary disease
    Beatriz Villegas
    Institut Cardiovasculaire Paris Sud, 6 avenue du Noyer Lambert, 91300, Massy, France
    J Invasive Cardiol 14:1-5. 2002
    ..this prospective study was performed to measure the percentage of patients eligible for elective multiple stenting of triple vessel coronary artery disease and to examine their short- and intermediate-term outcomes...
  21. doi request reprint Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization
    Darren Mylotte
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, and Hopital Claude Galien, Quincy, France
    JACC Cardiovasc Interv 6:115-25. 2013
    ....
  22. doi request reprint True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 5:207-14. 2012
    ..The purpose of this study was to evaluate the incidence of vascular complications and the predictors of Prostar failure for a "true percutaneous approach" in transfemoral transcatheter aortic valve implantation (TAVI)...
  23. ncbi request reprint Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: a dual-center registry
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
    Catheter Cardiovasc Interv 55:206-11. 2002
    ....
  24. doi request reprint Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry
    Beatriz Vaquerizo
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
    Circulation 119:2349-56. 2009
    ..The objective of this registry was to evaluate the 2-year outcome of elective percutaneous coronary intervention for unprotected LM disease with paclitaxel-eluting stents...
  25. doi request reprint Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the Edwards valve or the CoreValve
    Yusuke Watanabe
    Institut Cardiovasculaire Paris Sud, Massy, France
    Am J Cardiol 112:707-13. 2013
    ..31). In conclusion, in patients with annulus of intermediate size, similar device success and short-term and midterm outcomes were achieved with either of the valves, irrespective of the specific complications related to each valve...
  26. ncbi request reprint Stenting of bifurcation lesions using the Bestent: a prospective dual-center study
    Francois Gobeil
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 55:427-33. 2002
    ....
  27. doi request reprint Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2
    Bernard Chevalier
    Institut Cardiovasculaire Paris Sud, Massy Quincy, France
    Circ Cardiovasc Interv 2:188-95. 2009
    ..The newly developed Nobori coronary stent coated with a bioresorbable polymer, polylactic acid, and the antiproliferative agent Biolimus A9 has the potential to reduce restenosis by suppressing neointima formation...
  28. doi request reprint Potential mechanism of annulus rupture during transcatheter aortic valve implantation
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, 91300 Massy, France
    Catheter Cardiovasc Interv 82:E742-6. 2013
    ..In both cases, annulus rupture occurred after deployment of a balloon expandable valve suggesting that mechanical compression of this "vulnerable area" by calcification may cause annulus rupture...
  29. ncbi request reprint Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry
    Christian Spaulding
    Cardiology Department, Cochin Hospital, Rene Descartes University, Paris, France
    Eur Heart J 27:1054-60. 2006
    ..Because of the limited access to high PTCA volume centres in some areas, it has been suggested that PTCA could be performed in low-volume centres on AMI patients. Little data exist on the validity of this strategy in modern era PTCA...
  30. doi request reprint Duration of balloon inflation for optimal stent deployment: five seconds is not enough
    Thomas Hovasse
    Department of Interventional Cardiology, Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 81:446-53. 2013
    ..To assess the effect of the duration of stent inflation on stent expansion using digital stent enhancement (DSE)...
  31. doi request reprint Automated 3-dimensional aortic annular assessment by multidetector computed tomography in transcatheter aortic valve implantation
    Yusuke Watanabe
    Institut Cardiovasculaire Paris, Hôpital privé Jacques Cartier, Générale de Santé, Massy, France
    JACC Cardiovasc Interv 6:955-64. 2013
    ..1.sp1, 3mensio Medical Imaging BV, the Netherlands), in the assessment of patients undergoing transcatheter aortic valve implantation (TAVI)...
  32. pmc Percutaneous coronary intervention for bifurcation coronary disease
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Massy, France
    Heart 90:713-22. 2004
  33. ncbi request reprint A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction
    Christophe Loubeyre
    Institut Cardiovasculaire Paris Sud, Hôpital Claude Galien, Quincy Sous Senart, France
    J Am Coll Cardiol 39:15-21. 2002
    ....
  34. ncbi request reprint Delayed and recurrent cardiac tamponade following distal coronary perforation of hydrphilic guidewires during coronary intervention
    Federico De Marco
    Cardiologie Interventionelle, Institut Cardiovasculaire Paris Sud ICPS, Massy, France
    J Invasive Cardiol 20:E150-3. 2008
    ..In the second case, tamponade was successfully treated with immediate pericardial drainage, but tamponade recurred several days later...
  35. ncbi request reprint Less invasive PTCA of a gastroepiploic artery combining the transradial approach and 5 Fr guiding catheter: a case report
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 56:494-7. 2002
    ..In the case presented here, a gastroepiploic graft stenosis was treated by balloon angioplasty performed through a less invasive approach combining transradial access and use of 5 Fr guiding catheter...
  36. ncbi request reprint Management of cerebrovascular accidents during cardiac catheterization: immediate cerebral angiography versus early neuroimaging strategy
    Federico De Marco
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:560-8. 2007
    ..In contrast the use of immediate neuroimaging by means of MRI or CT scan in two cases delayed the implementation of appropriate therapy...
  37. ncbi request reprint Late or very late stent thrombosis can also occur with bare metal stents
    Andres Rosas Ramos
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:229-32. 2007
    ..In the second case, it occurred three years after the stenting procedure in a bare metal stent implanted in the circumflex artery of a patient who had also received two drug-eluting stents in the left anterior descending coronary artery...
  38. doi request reprint Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registr
    Anouska Moynagh
    Institut Jacques Cartier and Hopital Claude Galien, Institut Cardiovasculaire Paris Sud, Massy and Quincy, France
    EuroIntervention 9:452-62. 2013
    ..Using data from the French Left Main Taxus and the LEft MAin Xience registries, we compared two-year outcomes in consecutive patients from 2003-2008 using everolimus-eluting stents (EES) vs. paclitaxel-eluting stents (PES)...
  39. ncbi request reprint Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction
    Philippe Garot
    Institut Cardiovasculaire Paris Sud, Centre Hospitalier Claude Galien, 20 Route de Boussy, 91480 Quincy, France
    Circulation 115:1354-62. 2007
    ..Existing data suggest potential beneficial effects of early myocardial reperfusion, but the predictors of survival in these patients remain unknown...
  40. ncbi request reprint Use of a deflectable tip catheter to facilitate complex interventions beyond insertion of coronary bypass grafts: three case reports
    Helen Routledge
    Institute Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:862-6. 2007
    ..Use of the Venture Catheter, a deflectable tip 3.5F wire control catheter, facilitated successful percutaneous coronary intervention after prolonged, unsuccessful attempts at conventional guidewire passage...
  41. doi request reprint The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience
    Kentaro Hayashida
    Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
    Eur J Cardiothorac Surg 44:692-700. 2013
    ..The purpose of this study was to evaluate the efficacy and safety of the TAo-TAVI approach using both the Sapien XT and the CoreValve according to VARC criteria...
  42. doi request reprint 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents
    Helen C Routledge
    ICPS Institut Cardiovasculaire, Paris Sud, Massy, France
    JACC Cardiovasc Interv 1:358-65. 2008
    ....
  43. doi request reprint [Percutaneous aortic valve implantation: results and perspectives]
    Thomas Hovasse
    Hôpital privé Jacques Cartier, Institut Cardiovasculaire Paris Sud, 91300 Massy, France
    Presse Med 40:732-9. 2011
    ..This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects...
  44. doi request reprint Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock
    Philippe Garot
    Institut Cardiovasculaire Paris Sud, Quincy and Massy, France
    EuroIntervention 6:350-5. 2010
    ..Therefore, we hypothesised that statin therapy has an early beneficial effect among patients undergoing PCI for STEMI complicated by cardiogenic shock...
  45. ncbi request reprint Successful angioplasty of tripolar renal arteries in a single setting: a case report
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Invasive Cardiol 14:457-60. 2002
    ..PTRA combined with stenting is associated with good immediate and long-term results. This case report describes successful angioplasty of bilateral multiple renal arteries in a single setting with good immediate and follow-up results...
  46. ncbi request reprint Percutaneous aortic valve replacement: new hope for inoperable and high-risk patients
    Helen C Routledge
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
    J Invasive Cardiol 19:478-83. 2007
    ..The technique, initial results and the current limitations of the procedure are explained alongside the ongoing trials necessary in order that such therapy may eventually be made widely available...
  47. ncbi request reprint Collateral coronary circulation in the absence of obstructive coronary artery disease
    Rajpal Abhaichand
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Invasive Cardiol 14:331-3. 2002
    ..We believe that this vessel is of congenital origin and after reviewing the literature we describe the angiographic features that distinguish such a vessel from collaterals that are secondary to coronary stenosis or hypoxia...
  48. ncbi request reprint Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial
    Philippe Garot
    Institut Cardio vasculaire Paris Sud, Quincy, France
    J Am Coll Cardiol 46:606-12. 2005
    ..The aim of this research was to determine the influence of bifurcation lesions on the outcome of patients undergoing percutaneous coronary intervention (PCI) in the recent era...
  49. ncbi request reprint Stent supported angioplasty for coronary arterial stenosis following the arterial switch operation
    Rajpal Abhaichand
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 56:278-80. 2002
    ..We could not find a similar report in the literature...
  50. ncbi request reprint Acute coronary syndromes: direct stent for all?
    Christophe Loubeyre
    Institut Cardiovasculaire Paris Sud, Quincy, France
    J Invasive Cardiol 14:313-4. 2002
  51. ncbi request reprint Safety and feasibility of the radial approach for primary angioplasty in acute myocardial infarction during pregnancy
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Quincy, France
    J Invasive Cardiol 14:359-62. 2002
    ..We present a case of successful primary angioplasty in acute myocardial infarction during pregnancy via the transradial approach without complications. The patient had an uncomplicated recovery with normal left ventricular function...
  52. ncbi request reprint Noncoronary transradial angioplasty with coronary equipment: a less invasive technique
    G L Sharma
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
    Catheter Cardiovasc Interv 55:197-205. 2002
    ..With the miniaturization of equipment and improvements in technique, this approach will also become an excellent alternative for noncoronary interventions...
  53. ncbi request reprint Cause of death with bare metal and sirolimus-eluting stents
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 27:2815-22. 2006
    ..The aim of the present study was to compare the incidence and cause of death between patients who received sirolimus-eluting or bare metal stents...
  54. ncbi request reprint Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 356:998-1008. 2007
    ..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
  55. ncbi request reprint Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial
    Patrick W Serruys
    Thoraxcentre, Rotterdam, The Netherlands
    Circulation 106:798-803. 2002
    ..The goal of this intravascular ultrasound investigation was to provide a more detailed morphological analysis of the local biological effects of the implantation of a sirolimus-eluting stent compared with an uncoated stent...
  56. ncbi request reprint Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction
    Simon R Dixon
    Division of Cardiology, William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, MI 48073, USA
    Am J Cardiol 91:1454-7, A6. 2003
  57. ncbi request reprint Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial
    Jean Fajadet
    Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France
    Circulation 111:1040-4. 2005
    ..This analysis examined whether these beneficial effects persist over the longer term...
  58. ncbi request reprint Comparison of 5 French versus 6 French guiding catheters for transradial coronary intervention: a prospective, randomized study
    Francois Gobeil
    Notre Dame Hospital, Cardiology Department, Montreal University School of Medicine, 1560 Sherbrooke East Street, H2L 4M1, Montreal, Quebec, Canada
    J Invasive Cardiol 16:353-5. 2004
    ..9%; p = 0.05) because of a small radial artery. Transradial intervention using 5 Fr guiding catheters necessitates crossover to a 6 Fr catheter in 6.8% of cases, and offers no clear advantages over the 6 Fr technique...
  59. doi request reprint Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
  60. ncbi request reprint Gender-specific outcomes after sirolimus-eluting stent implantation
    Emilia Solinas
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 50:2111-6. 2007
    ..We examined the impact of gender on outcomes of patients undergoing percutaneous coronary intervention using sirolimus-eluting stents (SES)...
  61. ncbi request reprint Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)
    Remo Albiero
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:943-9. 2004
    ..e., percutaneous transluminal coronary angioplasty [PTCA]) for the treatment of patients with coronary in-stent restenosis (ISR)...
  62. ncbi request reprint Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial
    Alexandre Abizaid
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Eur Heart J 25:107-12. 2004
    ..007). Conclusion Diabetics treated with SES were associated with a virtual abolition of neointimal proliferation and low event rates at long-term follow-up...
  63. ncbi request reprint The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase
    Andrew T L Ong
    Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Am Heart J 151:1194-204. 2006
    ....
  64. ncbi request reprint Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis
    Muzaffer Degertekin
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 108:2747-50. 2003
    ..The aim of this study was to investigate the long-term intravascular ultrasound (IVUS) findings of ISA in patients who received SES...
  65. ncbi request reprint Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study
    Sigmund Silber
    Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
    J Interv Cardiol 16:491-7. 2003
    ..No other MACE were observed during the three-month follow-up period. Based on the findings of this study, direct stenting with the EXPRESS Stent appears feasible and is well tolerated...
  66. ncbi request reprint The NUGGET study: NIR ultra gold-gilded equivalency trial
    Nicolaus Reifart
    Main Taunus Heart Institute, Bad Soden, Germany
    Catheter Cardiovasc Interv 62:18-25. 2004
    ..e., higher neointimal hyperplasia in spite of a significantly better initial gain), with higher restenosis and similar MACE rates at 6 months...
  67. doi request reprint Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    Stephan Windecker
    Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
    Lancet 372:1163-73. 2008
    ..We compared the safety and efficacy of a biolimus-eluting stent (with biodegradable polymer) with a sirolimus-eluting stent (with durable polymer)...